{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:47:29Z","timestamp":1791002849661,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/emm.2017.213","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T03:01:52Z","timestamp":1510887712000},"page":"e396-e396","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases"],"prefix":"10.1038","volume":"49","author":[{"given":"Ruchi","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh","family":"Yazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joop","family":"van Baarlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0948-119X","authenticated-orcid":false,"given":"Won-Min","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Goossens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naftali","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"van Goor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1178-6195","authenticated-orcid":false,"given":"Scott L","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9430-1426","authenticated-orcid":false,"given":"Yujin","family":"Hoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-650X","authenticated-orcid":false,"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,17]]},"reference":[{"key":"BFemm2017213_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","volume":"214","author":"TA Wynn","year":"2008","unstructured":"Wynn TA . Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199\u2013210.","journal-title":"J Pathol"},{"key":"BFemm2017213_CR2","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/01.LAB.0000101911.53973.90","volume":"83","author":"A Desmouliere","year":"2003","unstructured":"Desmouliere A, Darby IA, Gabbiani G . Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003; 83: 1689\u20131707.","journal-title":"Lab Invest"},{"key":"BFemm2017213_CR3","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","volume":"180","author":"B Hinz","year":"2012","unstructured":"Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180: 1340\u20131355.","journal-title":"Am J Pathol"},{"key":"BFemm2017213_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","volume":"5","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto H, Mundel TM, Kieran MW, Kalluri R . Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006; 5: 1640\u20131646.","journal-title":"Cancer Biol Ther"},{"key":"BFemm2017213_CR5","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1084\/jem.20110551","volume":"208","author":"TA Wynn","year":"2011","unstructured":"Wynn TA . Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339\u20131350.","journal-title":"J Exp Med"},{"key":"BFemm2017213_CR6","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G . The myofibroblast: one function, multiple origins. Am J Pathol 2007; 170: 1807\u20131816.","journal-title":"Am J Pathol"},{"key":"BFemm2017213_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85\u201397.","journal-title":"Am J Pathol"},{"key":"BFemm2017213_CR8","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri R, Neilson EG . Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776\u20131784.","journal-title":"J Clin Invest"},{"key":"BFemm2017213_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA . Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871\u2013890.","journal-title":"Cell"},{"key":"BFemm2017213_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","volume":"179","author":"S Piera-Velazquez","year":"2011","unstructured":"Piera-Velazquez S, Li Z, Jimenez SA . Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074\u20131080.","journal-title":"Am J Pathol"},{"key":"BFemm2017213_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL . Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655\u20131669.","journal-title":"Gastroenterology"},{"key":"BFemm2017213_CR12","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/path.1427","volume":"200","author":"G Gabbiani","year":"2003","unstructured":"Gabbiani G . The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 2003; 200: 500\u2013503.","journal-title":"J Pathol"},{"key":"BFemm2017213_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-5926-6-7","volume":"6","author":"OA Gressner","year":"2007","unstructured":"Gressner OA, Weiskirchen R, Gressner AM . Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol 2007; 6: 7.","journal-title":"Comp Hepatol"},{"key":"BFemm2017213_CR14","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jhep.2015.02.039","volume":"62","author":"C Trautwein","year":"2015","unstructured":"Trautwein C, Friedman SL, Schuppan D, Pinzani M . Hepatic fibrosis: concept to treatment. J Hepatol 2015; 62: S15\u2013S24.","journal-title":"J Hepatol"},{"key":"BFemm2017213_CR15","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR . Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18: 1028\u20131040.","journal-title":"Nat Med"},{"key":"BFemm2017213_CR16","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fphar.2014.00131","volume":"5","author":"SK Agarwal","year":"2014","unstructured":"Agarwal SK . Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol 2014; 5: 131.","journal-title":"Front Pharmacol"},{"key":"BFemm2017213_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.bbadis.2012.10.005","volume":"1832","author":"NC Henderson","year":"2013","unstructured":"Henderson NC, Sheppard D . Integrin-mediated regulation of TGFbeta in fibrosis. Biochim Biophys Acta 2013; 1832: 891\u2013896.","journal-title":"Biochim Biophys Acta"},{"key":"BFemm2017213_CR18","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1242\/jcs.03098","volume":"119","author":"JD Humphries","year":"2006","unstructured":"Humphries JD, Byron A, Humphries MJ . Integrin ligands at a glance. J Cell Sci 2006; 119: 3901\u20133903.","journal-title":"J Cell Sci"},{"key":"BFemm2017213_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO . Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110: 673\u2013687.","journal-title":"Cell"},{"key":"BFemm2017213_CR20","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1038\/nm.3282","volume":"19","author":"NC Henderson","year":"2013","unstructured":"Henderson NC, Arnold TD, Katamura Y, Giacomini MM, Rodriguez JD, McCarty JH et al. Targeting of alphav integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med 2013; 19: 1617\u20131624.","journal-title":"Nat Med"},{"key":"BFemm2017213_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0092-8674(00)80545-0","volume":"96","author":"JS Munger","year":"1999","unstructured":"Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999; 96: 319\u2013328.","journal-title":"Cell"},{"key":"BFemm2017213_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1748-1716.2007.01718.x","volume":"190","author":"SN Popova","year":"2007","unstructured":"Popova SN, Lundgren-Akerlund E, Wiig H, Gullberg D . Physiology and pathology of collagen receptors. Acta Physiol (Oxf) 2007; 190: 179\u2013187.","journal-title":"Acta Physiol (Oxf)"},{"key":"BFemm2017213_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1006\/dbio.2001.0363","volume":"237","author":"CF Tiger","year":"2001","unstructured":"Tiger CF, Fougerousse F, Grundstrom G, Velling T, Gullberg D . \u03b111\u03b21 integrin is a receptor for interstitial collagens involved in cell migration and collagen reorganization on mesenchymal nonmuscle cells. Dev Biol 2001; 237: 116\u2013129.","journal-title":"Dev Biol"},{"key":"BFemm2017213_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ydbio.2004.03.006","volume":"270","author":"SN Popova","year":"2004","unstructured":"Popova SN, Rodriguez-Sanchez B, Liden A, Betsholtz C, Van Den Bos T, Gullberg D . The mesenchymal alpha11beta1 integrin attenuates PDGF-BB-stimulated chemotaxis of embryonic fibroblasts on collagens. Dev Biol 2004; 270: 427\u2013442.","journal-title":"Dev Biol"},{"key":"BFemm2017213_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/cvr\/cvs259","volume":"96","author":"I Talior-Volodarsky","year":"2012","unstructured":"Talior-Volodarsky I, Connelly KA, Arora PD, Gullberg D, McCulloch CA . \u03b111 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy. Cardiovasc Res 2012; 96: 265\u2013275.","journal-title":"Cardiovasc Res"},{"key":"BFemm2017213_CR26","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1620\/tjem.220.319","volume":"220","author":"E Honda","year":"2010","unstructured":"Honda E, Yoshida K, Munakata H . Transforming growth factor-beta upregulates the expression of integrin and related proteins in MRC-5 human myofibroblasts. Tohoku J Exp Med 2010; 220: 319\u2013327.","journal-title":"Tohoku J Exp Med"},{"key":"BFemm2017213_CR27","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.matbio.2009.11.003","volume":"29","author":"N Lu","year":"2010","unstructured":"Lu N, Carracedo S, Ranta J, Heuchel R, Soininen R, Gullberg D . The human alpha11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-beta1 in a Smad- and Sp1-dependent manner. Matrix Biol 2010; 29: 166\u2013176.","journal-title":"Matrix Biol"},{"key":"BFemm2017213_CR28","doi-asserted-by":"publisher","first-page":"10434","DOI":"10.1074\/jbc.M109.078766","volume":"285","author":"S Carracedo","year":"2010","unstructured":"Carracedo S, Lu N, Popova SN, Jonsson R, Eckes B, Gullberg D . The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J Biol Chem 2010; 285: 10434\u201310445.","journal-title":"J Biol Chem"},{"key":"BFemm2017213_CR29","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/onc.2015.254","volume":"35","author":"R Navab","year":"2016","unstructured":"Navab R, Strumpf D, To C, Pasko E, Kim KS, Park CJ et al. Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer. Oncogene 2016; 35: 1899\u20131908.","journal-title":"Oncogene"},{"key":"BFemm2017213_CR30","doi-asserted-by":"publisher","first-page":"8352","DOI":"10.1073\/pnas.0907676107","volume":"107","author":"V Vaira","year":"2010","unstructured":"Vaira V, Fedele G, Pyne S, Fasoli E, Zadra G, Bailey D et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci USA 2010; 107: 8352\u20138356.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFemm2017213_CR31","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994; 20: 15\u201320."},{"key":"BFemm2017213_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","volume":"16","author":"R Kramann","year":"2015","unstructured":"Kramann R, Schneider RK, DiRocco DP, Machado F, Fleig S, Bondzie PA et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015; 16: 51\u201366.","journal-title":"Cell Stem Cell"},{"key":"BFemm2017213_CR33","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki Y, Okazaki I . Emerging insights into transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 2007; 56: 284\u2013292.","journal-title":"Gut"},{"key":"BFemm2017213_CR34","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/embor.2009.276","volume":"11","author":"C Margadant","year":"2010","unstructured":"Margadant C, Sonnenberg A . Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 2010; 11: 97\u2013105.","journal-title":"EMBO Rep"},{"key":"BFemm2017213_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1124\/mol.114.095141","volume":"87","author":"L Hu","year":"2015","unstructured":"Hu L, Lin X, Lu H, Chen B, Bai Y . An overview of hedgehog signaling in fibrosis. Mol Pharmacol 2015; 87: 174\u2013182.","journal-title":"Mol Pharmacol"},{"key":"BFemm2017213_CR36","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jhep.2013.01.009","volume":"58","author":"P Olinga","year":"2013","unstructured":"Olinga P, Schuppan D . Precision-cut liver slices: a tool to model the liver ex vivo. J Hepatol 2013; 58: 1252\u20131253.","journal-title":"J Hepatol"}],"container-title":["Experimental & Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/emm2017213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017213","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/emm.2017.213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/emm2017213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:21:21Z","timestamp":1684416081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/emm2017213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFemm2017213"],"URL":"https:\/\/doi.org\/10.1038\/emm.2017.213","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"9 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JP is the founder and stakeholder of ScarTec Therapeutics BV, Enschede, The Netherlands. The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}